Paola Donaji Contreras Pineda

Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Magnus Essand

E-post:: paola.contreras@igp.uu.se
Besöksadress:: Dag Hammarskjölds väg 20
751 85 Uppsala
Postadress:: Rudbecklaboratoriet
751 85 UPPSALA

Ladda ned kontaktuppgifter för Paola Donaji Contreras Pineda vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Magnus Essand

Publikationer

Senaste publikationer

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Ladda ner fulltext (pdf) av Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Ali, Arwa; Contreras, Paola; Darweesh, Mahmoud; Andersson, Leif et al.

Ingår i Molecular Therapy Nucleic Acids, 2024
- DOI för Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Ladda ner fulltext (pdf) av Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Alla publikationer

Artiklar i tidskrift

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Ladda ner fulltext (pdf) av Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response

Ali, Arwa; Contreras, Paola; Darweesh, Mahmoud; Andersson, Leif et al.

Ingår i Molecular Therapy Nucleic Acids, 2024
- DOI för Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Ladda ner fulltext (pdf) av Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response